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Abstract
Background: Although patients in palliative care commonly report high emotional and spiritual needs, effective
psychosocial treatments based on high quality studies are rare. First research provides evidence for benefits of
psychosocial interventions in advanced cancer care. To specifically address end-of-life care requirements, life review
techniques and creative-arts based therapies offer a promising potential. Therefore, the present study protocol
presents a randomized controlled trial on the effectiveness of a newly developed music therapy technique that is
based on a biographically meaningful song (“Song of Life”; SOL).
Methods: In a design with two parallel arms, 104 patients at two palliative care units will be randomly assigned to
three sessions of either SOL (experimental group) or relaxation exercises (control group). Improvements in the
psychological domain of quality of life will be the primary endpoint, while secondary outcomes encompass spiritual
well-being, ego-integrity, overall quality of life, and distress. Additionally, caregivers will be asked to provide
feedback about the treatment. Assessment of biopsychological stress markers and qualitative analysis of perceived
strengths and weaknesses will complement data collection.
Discussion: Based on the results of a previous pilot study, we dedicated considerable efforts to optimizing the
intervention and selecting appropriate outcomes for the present trial. We are confident to have designed a
methodologically rigorous study that will contribute to the evidence-base and help to develop the potential of
psychosocial interventions in palliative care.
Trial registration: German Clinical Trials Register (DRKS) – DRKS00015308 (date of registration: September 07th 2018).
Keywords: Music therapy, Palliative care, Cancer, Randomized controlled trial, End-of-life, Quality of life, Spiritual well-
being, Distress, Ego-integrity, Cortisol, Stress, Heart rate variability
Background
How to preserve the psychosocial, spiritual and existen-
tial integrity of people facing an incurable disease is
considered one of the main challenges of palliative care
[1]. Although palliative care aims to support terminally
ill patients and their relatives on a physical, psychosocial
and spiritual level [2], effective treatments have mainly
been developed and investigated with a bio-medical
focus on pain or dyspnea, for instance [3]. Nevertheless,
psychological distress (e.g., depression, anxiety or feel-
ings of hopelessness) and spiritual concerns (e.g., regard-
ing purpose or meaning in life) are highly prevalent in
the terminal phases of a life-threatening disease [4, 5].
Thus, the recent advances of psychosocial interventions
addressing these needs offer huge potential for providing
holistic palliative care [4].
Interestingly, the link between psychological and
biological mechanisms in terminal disease offers an
encouraging psychoneuroimmunologcial perspective for
* Correspondence: marco.warth@med.uni-heidelberg.de
†Marco Warth and Friederike Koehler contributed equally to this work.
1Institute of Medical Psychology, Center for Psychosocial Medicine, University
Hospital Heidelberg, Bergheimer Str. 20, 69115 Heidelberg, Germany
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Warth et al. BMC Palliative Care           (2019) 18:14 
https://doi.org/10.1186/s12904-019-0397-6
psychosocial interventions [6]. On the one hand, the
stress a patient experiences can increase through the diag-
nosis and course of a life-threatening illness like cancer,
while on the other hand stress itself can also affect disease
outcomes like tumor growth, progression and metastasis
[7]. The human biological stress response is primarily
adaptive and consists of an increased activation of the
hypothalamic-pituitary-adrenal (HPA) and the autono-
mous nervous system (ANS). The resulting elevated levels
of circulating glucocorticoids and catecholamines can sup-
press immunological activities and deteriorate symptoms,
especially in chronical diseases like cancer [8]. Therefore,
beyond pharmacological treatments, stress-reducing
psychosocial interventions have been developed and
shown to improve immune function [9, 10].
Most commonly, psychosocial treatments in palliative
care are categorized into cognitive-behavioral therapy
(CBT), mindfulness-based interventions, life review or
meaning-centered interventions, and creative-arts based
therapies [11]. Although CBT has shown to improve
depression and quality of life in patients with advanced
cancer [12], the treatment manuals mostly fail to con-
sider the unique conditions of end-of-life care, such as
rapid physical declines or limited life expectancy [13].
Mindfulness-based interventions focus on the cultivation
and practice of mindfulness (i.e., purposeful, nonjudg-
mental, moment-to-moment awareness) [14]. In cancer
care, research has proliferated over the past decade with
evidence on improvements in psychological distress and
sleep disturbances as well as markers of immune func-
tion and autonomous nervous system activity [15].
Despite its potential for palliative care settings, a recent
review on short-term mindfulness interventions [16]
identified only a limited number of clinical trials with
low quality of evidence.
To specifically address the psychological and existential
distress of terminally ill patients, life review interventions
such as dignity therapy [17, 18], the structured life review
[19], or meaning-centered therapy [20] have recently
emerged. According to developmental psychologist Erik
Erikson, the central themes of the final stages of life can
be outlined as generativity (i.e., producing something
lasting of oneself ) and ego-integrity (i.e., a retrospective
sense of acceptance and meaning of one’s life) [21]. The
life review techniques approach generativity and
ego-integrity of terminally ill patients through creating an
intellectual or physical legacy, e.g., a written transcript on
the patient’s life history and hopes for their loved ones or
a biographical photo book [13]. Although patients, rela-
tives and professionals generally report high satisfaction
and an improved end-of-life experience through life
review interventions [17, 22], empirical findings remain
inconclusive concerning reproducible effects on validated
quality of life measures [23, 24]. Cumulative evidence is
offered by a recent meta-analysis demonstrating moderate
effects on spiritual well-being, general distress and quality
of life, but with a high risk of bias [25].
Arts and music in creative-arts based therapies can
also be used as a means to facilitate feelings of meaning
and a psycho-spiritual integration of life experiences in
terminally ill patients and caregivers [26, 27]. The use of
music therapy in multidisciplinary palliative care dates
back to the 1970s, when the Canadian music therapist
Susan Munro as a pioneer systematically described her
work with palliative patients on a physical, psychological,
social, and spiritual level [28]. Nowadays, music therapy
has become a widely implemented and explicitly recom-
mended complementary therapy in palliative treatment
[29]. Music therapy is generally defined as “a systematic
process of intervention wherein the therapist helps the
client to promote health, using music experiences and
the relationships that develop through them as dynamic
forces of change” [30]. In clinical palliative care practice,
music therapy aims to improve quality of life through
the relief of physical symptoms and psychological diffi-
culties by offering comfort, facilitating communication
and spiritual experiences [31].
Music therapy includes active techniques (the patient
is actively involved in the production or reproduction of
music) as well as receptive techniques (the patient
listens to live or prerecorded music). Techniques in
palliative care have been categorized as [32]: receptive
(e.g., imagery), creative (e.g., songwriting), recreative
(e.g., instrument playing) and combined (e.g., musical life
review). The latter area indicates a possible synthesis of
life review techniques with the help of music, especially
concerning the improvement of both psychological and
existential distress [32]. Despite a lack of empirical
research, Sato [33] proposes a first experience-based
Musical Life Review Model describing the stimuli,
themes, responses, evaluation and therapeutic outcomes
of this process.
While clinical practice emphasizes the benefits of
music therapy in end-of-life care [28], there is still insuf-
ficient research to reliably conclude a favorable effect
due to a lack of empirical investigations in both quantity
and quality. Most palliative care referrals for music
therapy focus on pain and quality of life with a low level
of evidence [34]. For instance, music therapy has been
frequently associated with pain reduction [35, 36] and
enhancement of physical comfort [37, 38]. With regards
to quality of life, patients receiving music therapy often
report higher psychophysiological well-being [39] and
subjective well-being [40] as well as improvements in
emotional distress [41], anxiety and mood [36, 42, 43].
Additionally, single studies report an enhancement of
spirituality [44] and lowering of salivary cortisol levels
[43] after music therapy. Even family caregivers and staff
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members attribute music therapy an important role in
the end-of-life experience [45]. However, the abovemen-
tioned studies reveal a high risk of bias (e.g. no
randomization or allocation concealment, selective
reporting). Thus, methodologically rigorous studies on
clearly defined music therapy interventions with com-
mon outcome measures are urgently needed.
Overall, to contribute to this important but underrep-
resented topic of psychosocial interventions in palliative
care, the general aim of the present study is to evaluate
the effectiveness of the newly developed music therapy
technique “Song of Life” in terminally ill patients with
regard to the psychological and spiritual domain of qual-
ity of life. Based on a biographically meaningful song,
SOL integrates aspects of music therapy, musical life
review, and dignity therapy. In the present study, we will
compare the effects of SOL to the ones of a control group
which will participate in live guided relaxation exercises.
Methods / design
Participants and setting
This multicenter study will be conducted in parallel at
two sites: The University Palliative Care Unit at the St.
Vincentius Hospital in Heidelberg, Germany, and the
Interdisciplinary Palliative Care Unit at the University
Medical Center in Mainz, Germany. Patients admitted
to these units will be screened for eligibility based on
their medical record and information from personal con-
tact. Patients are eligible for participation if they meet
the following criteria: a) Palliative care according to OPS
8–982/OPS 8.98e or estimated life expectancy < 12
months, b) age ≥ 18 years, c) ability to provide informed
consent, d) sufficient understanding of German lan-
guage, d) clinical estimation of life expectancy > 1 week,
e) no cognitive or auditory impairments (including
severe psychiatric symptoms). Criteria d) and e) will be
assessed by the treating physician.
Patients will be asked to name a family member, friend
or other close person who is currently involved in pro-
viding assistance (subsequently called caregiver) whom
we may contact for a caregiver evaluation of the inter-
vention. Caregivers will be included in this study if they
a) are 18 years or older, and b) show sufficient under-
standing of German language. All participants will be
informed by the outcome assessor and need to sign
consent before participation.
Study design
The study utilizes a prospective, randomized controlled
design with two parallel arms. Patients will be randomly
assigned to three sessions of either music therapy (EG)
or relaxation exercises (CG). We will not give informa-
tion about which of the two alternative treatments is the
experimental and which is the control condition. Hence,
patients will be blinded with regard to the study hypoth-
eses. It will not be possible to blind the therapists and
outcome assessors, but all data will be assessed by per-
sons different than the study therapists (i.e. study nurse,
doctoral student). We will use a computer-based block
randomization procedure with a block size of 8. A
random sequence for group assignment will be created
before the first patient is randomized. Based on this se-
quence, we will use the SNOSE-method [46] to conceal
allocation. We expect benefits and improvements in
both treatment groups with a superiority of the SOL
intervention. The study design is summarized in Fig. 1.
Patient procedures
Eligible patients will be informed about the study goals,
procedures, data protection plan, risks, and benefits.
Each patient agreeing to participate and providing in-
formed consent will undergo a baseline assessment (T0)
including questionnaire data on different quality of life
domains. Afterwards, a study assistant will open a
Fig. 1 Study design. Notes: S = therapeutic session, T = time of assessment
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serially numbered, sealed envelope containing informa-
tion about group assignment. In each group, appoint-
ments will be made for three sessions of either music
therapy (EG) or relaxation (CG), ideally on consecutive
afternoons. Each of the three sessions is enclosed by a
pre-to-post assessment of momentary distress. For both
groups, the second session contains a psychobiological
intra-session assessment. Post intervention data (T1) will
be collected after completion of the third session includ-
ing all variables assessed at baseline (T0) plus a retro-
spective evaluation of treatment quality. Sessions and
assessments will last for approximately 45 min each day.
Figure 2 depicts an overview of the timing of assess-
ments. The interventions and outcomes will be de-
scribed in detail in the following paragraphs.
Caregiver procedures
If the caregiver has given consent to participate, we will
contact the caregiver proposed by the patient either in per-
son or by phone after completion of the last session. The
reason for the inclusion of caregiver evaluations in the
study design is the possibility to gather indirect informa-
tion on the endurance of effects. Caregivers will be pro-
vided with all relevant information concerning their study
participation and asked to sign the consent form. Subse-
quently, they will participate in a brief structured interview
on their retrospective evaluation of treatment quality (T1).
We will ask for permission to contact the caregiver again
after 8 weeks (T2). On this follow-up assessment, care-
givers will answer the same questions as at T1 in a tele-
phone interview. If the caregiver expresses intense distress
or unease, we will offer to postpone the appointment. To
be included in the analysis, follow-up assessments (T2)
need to be completed within 16 weeks after T1.
Interventions
The intervention in the EG is a newly developed music
therapy technique specifically designed to address
psycho-spiritual needs in an end-of-life care context by
using a creative-arts based technique (“Song of Life”).
The core element of SOL is a biographically meaningful
song, based on the “Song of kin” music therapy tech-
nique of neonatal care [47, 48]. The song of kin is a
parent-selected song performed as a lullaby and syn-
chronized with the infant’s vital signs [49]. The
SOL-technique has shown to be feasible and accepted in
palliative care in a recent pilot study [50]. We expect
each of the three therapeutic sessions (S) to last between
20 and 35min:
 S1 (Interview): The first session comprises an
interview including several biographical questions
with a focus on the musical background of the
person. The last items specifically aim to identify the
patient’s SOL, which is a song that has a high
biographical relevance and the potential to arouse
strong emotional reactions [47, 48, 51]. Our pilot
study [51] showed that such a song is often
associated with social bounds (e.g. romantic partner,
children, parents), biographic events (e.g. marriage,
child’s birth), or certain places (e.g. birthplace,
vacation). The first session ends with the offer to
perform a brief music therapy relaxation exercise
using the monochord and vocal improvisation.
 S2 (“Song of Life”): The second session will be
carried out the next afternoon to give the therapist
time to prepare the patient’s SOL. The therapist uses
the guitar/piano and her voice and first initiates a
brief relaxation exercise accompanied by gentle
Fig. 2 Patient assessments. Notes: HRV = heart rate variability, BVP-A = blood volume pulse amplitude, S = therapeutic session, T = overall timing of
assessment, Q = timing of questionnaire assessment, D = timing of distress assessment, C = timing of cortisol /α-amylase assessment, H = timing of
cardiovascular recordings, I = timing of interview
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sounds on the instrument in the musical key of the
following song. If possible, the musical beat entrains
to the patients’ breathing cycle and the therapist
gradually reduces the meter [52]. If applicable, the
therapist can include quotations of important
sentences from the interview in S1. The music
afterwards turns into a life performance of the SOL
in a lullaby style. This requires the therapist to
translate the original version into a slow 3/4-rhythm
or 6/8-rhythm. The song performance is faded out
with a diminuendo of the hummed song chorus.
 S3 (“Reflection”): The live performance will be
recorded and edited after S2 by the therapist or
study assistant, and will be handed over to the
patient in S3. Therapist and patient can complete
the intervention by listening together to the
recording and reflect on the statements and
messages. After this initial phase of free
conversation, the therapist will guide the talk
according to themes of a semi-structured qualitative
interview on the patient’s perceptions, attitudes, and
beliefs towards the strengths and weaknesses of the
SOL intervention. At the end, the therapist can offer
to again play a brief music therapy relaxation on the
monochord.
The control group intervention consists of three
sessions of relaxation exercises, carried out by the
music therapists involved in this study. A professional
mindfulness trainer created three standardized, con-
secutive exercises for supine positions for the purpose
of this study. Each exercise will last for approximately
20 min. Elements of these sessions are guided relax-
ation, focused breathing, and mindfulness. The tech-
niques will not contain musical elements and will not
target biographical or spiritual themes. Therapists at
both study sites have been trained in conducting the
SOL and relaxation treatment before the onset of the
intervention period.
As study participation is voluntary, the patient can
cancel the intervention at any given point (e.g., due to
worsening physical states). In this case, it remains the
patient’s decision whether the data collected up to this
point should be deleted. If the patient consents,
self-report data on the primary and secondary outcomes
(see below) will be collected together with reasons for
drop-out.
Outcomes
Previous psychosocial research often used generic quality
of life measures, palliative performance, or the concept of
dignity as the primary outcome and faced difficulties in
identifying significant effects on these constructs (which
were operationalized including items on functional or
physical state) [53]. The present SOL intervention is as-
sumed to work on an emotional and spiritual level. There-
fore, improvement in the psychological domain of quality
of life (a1) is chosen as the primary patient endpoint, while
the secondary outcomes encompass spiritual well-being
(b1), ego-integrity (b2), general quality of life (b3), distress
(b4), and the retrospective evaluation of the interventional
benefits (b5). To gather additional information about the
mechanisms underlying a potential effect, we will assess
psychobiological markers of stress (c1) as well as subject-
ive beliefs and attitudes towards the treatments in a quali-
tative interview (c2). As stated above, the family
caregiver’s perspective will be captured both after the
intervention and 8–16 weeks later (d1). A study assistant
and a doctoral student will carry out all outcome assess-
ment, including questionnaires, photoplethysmography,
saliva samples, and caregiver interviews.
Table 1 gives an overview of the study outcomes for
patients and family caregivers. The timing of assess-
ments can be found in Fig. 2.
Primary outcome
1) The psychological subscale of the McGill Quality of
Life Questionnaire - Revised (MQOL-R) [54, 55] will be
Table 1 Study outcomes
Primary outcome Secondary outcomes Exploratory analyses
Patient • a1: Quality of life – psychological
(MQOL-R, 4 items, T0-T1)
• b1: Spiritual well-being – meaning/peace
(FACIT-Sp, 8 items, T0-T1)
• b2: Ego-integrity (Brief Measure of Generativity
and Ego-Integrity, 5 items, T0-T1)
• b3: Quality of life - global
(MQOL-R, 1 item, T0-T1)
• b4: Distress (NCCN Distress Thermometer,
1 item, pre-post each session)
• b5: Retrospective evaluation
(Feedback Questionnaire, 8 Items, T1 only)
• c1: Biomarkers of stress:
▪ HPA-axis (cortisol)
▪ Sympathetic nervous system (salivary α-amylase,
peripheral blood flow)
▪ Parasympathetic nervous system (HRV)
• c2: Strengths and weaknesses of the intervention;
Beliefs about working mechanisms
(qualitative interview)
Caregiver • d1: Retrospective evaluation
(Feedback Questionnaire, 12 items, T1-T2)
FACIT-Sp Functional Assessment of Chronic Illness Therapy – Spiritual Well-being, MQOL-R McGill Quality of Life Questionnaire Revised, NCCN National
Comprehensive Cancer Network, HPA hypothalamic-pituitary-adrenal, HRV heart rate variability, T0 baseline assessment, T1 post intervention assessment
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used to measure changes in emotional well-being at the
end of life from T0 (pre intervention) to T1 (post inter-
vention). The MQOL was originally developed in 1996
for patients with life-threatening diseases and has
recently been shortened and revised [56]. The current
version consists of 14 items and four subscales (physical,
psychological, existential, social), which all showed
acceptable internal consistency. Confirmatory factor
analysis provided support for the assumed measurement
structure [56]. The psychological subscale contains 4
items on 11-point scales asking for issues related to
depression and anxiety in the past 2 days.
Secondary outcomes
1) We will assess changes on the 8-item meaning/
peace-scale of the Functional Assessment of Chronic
Illness Therapy - Spiritual Well-Being (FACIT-Sp) to
measure non-religious aspects of spiritual well-being.
The FACIT-Sp is an extended version of the Functional
Assessment of Cancer Therapy – General (FACT-G) and
is commonly used in cancer and palliative care research.
Adequate psychometric properties were identified for
both the FACT-G [57] and the FACIT-Sp [58]. We will
reduce the time frame in the items from seven to three
days.
2) According to Erikson’s stages of psychosocial devel-
opment [21], to gather acceptance and a sense of meaning
regarding one’s past life is an important developmental
task in the last stage of life. We will measure progress in
this adaption process using the 5-item ego-integrity sub-
scale of the Brief Measure of Generativity and
Ego-Integrity [59]. The questionnaire’s factor structure has
been confirmed in a validation study.
3) The MQOL-R’s overall quality of life single-item
scale [56] will be used to briefly measure treatment
effects on general well-being. The item asks for overall
quality of life during the last 48 h from very bad (0) to
excellent (10). The abovementioned secondary outcomes
b1 to b3 will all be assessed at baseline (T0) and after
completion of session 3 (T1).
4) Additionally, we will utilize a modified version of
the NCCN Distress Thermometer [60] before and after
each session to monitor changes in momentary distress
(D1-D6, Fig. 2). The single-item scale has a response
range from no distress (0) to extreme distress (10). The
original version is a commonly used screening instru-
ment in cancer care and research asking for distress in
the past week, while an existing modified and more
change-sensitive version asking for current distress will
be used in the present study [61].
5) Post-intervention assessment (T1) will be comple-
mented by a shortened and modified version of the
retrospective Feedback Questionnaire, previously used in
dignity therapy research [17]. We will use eight items on
a 5-point scale covering aspects of the patient’s subjective
perception of treatment effects. For each item, patients
can state reasons for their rating in an open format.
Exploratory analyses
1) In order to understand more about the mechanisms
underlying a potential treatment effect, we will collect
and record psychobiological data on stress reactivity
during session 2 (which contains the performance of the
SOL). Due to the paucity of research regarding the
effects of psychosocial interventions on biological stress
markers in palliative care, we decided to rather explore
trajectories in a mechanistic approach than to state
explicit hypotheses. The psychobiological assessments in
this study aim at monitoring states and changes in the
following regulatory systems:
 Hypothalamic-pituitary-adrenal (HPA) system via
salivary cortisol
 Sympathetic nervous system (SNS) via salivary α-
amylase and peripheral blood flow
 Parasympathetic nervous system (PNS) via heart
rate variability (HRV)
It is important to note that these stress markers will
be collected non-invasively by means of saliva samples
(cortisol, α-amylase) and photoplethysmography (blood
flow, HRV) aiming to minimize patient burden. The tim-
ing of assessments is depicted in Fig. 2. Saliva samples
will be collected at three measurement times during
session 2 (C1-C3, Fig. 2) for the analysis of cortisol and
α-amylase. These therapy sessions and data collection
will preferably take place at standard times during the
day (between 2 pm and 6 pm).
Cortisol is the end-product of a cascade of neuroendo-
crine responses to physically or psychologically challen-
ging situations. As free cortisol concentration in saliva
reaches its peak approximately 20 min after central
activation of the HPA axis in response to a stimulus
[62], the measurement points C1-C3 correspond to: 20
min. before Baseline (C1), pre intervention (C2), and
post intervention (C3). The Cortisol Salivette® (Sarstedt,
Nümbrecht, Germany) will be used for saliva sampling.
Patients are asked to chew on a small synthetic swab for
1 min for each saliva collection. Swabs will be placed in
sterile plastic centrifugation tubes. All samples will be
stored at − 80 °C at the laboratory of the Institute of
Medical Psychology (IMP), where they will later be
centrifuged and analyzed using standard commercially
available ELISA.
We will additionally calculate concentrations of saliv-
ary α-amylase (sAA) from the same saliva samples as a
measure of SNS activity. sAA is an enzyme mainly
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secreted by the parotid glands in response to adrenergic
innervation and has thus been studied as a proxy for the
sympathetic modulation of acute responses to stress
[63–65]. Short-term increases in sAA release were ob-
served in psychologically challenging situations [66] and
in response to pharmacological stimulation of adrenergic
receptors [67].
We acknowledge the dependence of the endocrine
biomarkers on exogenous glucocorticoids, chemother-
apy, and opioid administration [68, 69]. The majority
of patients in palliative care requires medication in-
take from multiple of these classes. Our interest,
however, lies not in the absolute cortisol levels, but in
the reactivity to the interventions provided, and
hence, in the exploration of intra-individual change
over time.
Additionally, we will use photoplethysmography for
non-invasive, continuous recordings of participants’
autonomic response before, after, and during the inter-
ventions. A Blood Volume Pulse Sensor (biosignalplux,
Lisbon, Portugal) will be placed on the index fingertip of
the non-dominant hand, detecting relative changes in
peripheral circulation [70]. The time point of the R-wave
is used to extract inter-beat-intervals (IBI) between
successive heartbeats in milliseconds. HRV parameters
can be derived for consecutive time segments of 5 min
duration [71]. High-frequent HRV is in indicator for
vagal modulation of cardiac outflow [72–75] and has
shown to correspond to self-ratings of relaxation and
well-being in response to psychosocial interventions in
palliative care [76, 77].
The amount of peripheral blood flow in the finger-
tips’ capillaries is predominantly subject to adrenergic
innervation by the SNS, leading to tonic vasoconstric-
tion. An increase in blood volume pulse amplitude
(BVP-A) is therefore associated with a reduction in
sympathetic arousal. Thus, the mean BVP-A of each
5-min segment will be considered an inversely related
index of vascular sympathetic tone [70, 78–80]. We
will continuously record the first 20 min of session 2
(H1) which includes the live-performance of the
chosen SOL, and another 5-min segment 20 min later
(H2), in parallel to saliva sample C3 (Fig. 2).
2) After an individual reflection conversation about
the SOL and listening to the music, the study therapists
will guide the second part of session 3 on the basis of a
semi-structured interview (I1, Fig. 2). Open questions
will address perceived strengths and weaknesses of the
treatment, possible adverse effects as well as subjective
explanations for potential effects. Our goal is to gain
additional insights about the underlying mechanisms of
the SOL intervention. The qualitative interview will last
for approximately 10 min and will be carried out and re-
corded only in the EG.
Caregiver evaluation
The retrospective patient Feedback Questionnaire exists
in a family caregiver version, offering the opportunity to
explore the duration of effects from a caregiver perspec-
tive [1, 81]. In case of prior consent, the caregivers’
evaluation of treatment quality will therefore be assessed
after the treatment (T1) and 8–16 weeks later (T2).
Data monitoring and management
Data collection and conduction of trial will be moni-
tored by the principal investigators. Adverse or unin-
tended effects of interventions or conduct will be
reported and managed in standard palliative care. In
order to protect confidentiality, all data and biomaterial
will be collected and stored for 10 years in a pseudony-
mized form at the Center for Psychosocial Medicine at
University Hospital Heidelberg. Only the principal inves-
tigators will have access to the assignment key. No third
parties are allowed inspection of personal data. After the
end of the research project, data will be published in
online repositories in an anonymized form.
Data analysis
Data will primarily be analyzed within an intention-
to-treat approach. Results will be tested for robustness
in comparison to a per-protocol-analysis (sensitivity ana-
lyses). Primary hypotheses tests will be conducted with
analyses of co-variance (ANCOVA). The study design
contains two independent variables to predict variance
in the primary outcome: 2 groups (between-subjects
factor) * 2 measurement times (within-subjects factor).
In order to increase statistical power, the ANCOVA
models will treat pre-intervention baseline data as a
covariate and group assignment as a fixed factor [82].
The following primary hypotheses will be tested in a
confirmatory ANCOVA with a type-I error probability
of α = 0.05: There is a significant effect of group assign-
ment on psychological quality of life after the interven-
tion (while controlling for baseline differences). Group
differences in the changes in secondary outcomes will be
tested accordingly without adjustment for multiple test-
ing, due to the a priori distinction between primary and
secondary outcomes and the likelihood of the outcomes
to correlate.
In addition to statistical significance, we will report
descriptive statistics and effect size estimates. Biomarker
analysis will be conducted by use of multilevel modeling,
as repeated observations are nested within participants,
and experience from previous research revealed substan-
tial heterogeneity in slopes and trajectories among
severely ill patients [77, 83]. Multilevel modeling can be
further used for subgroup analysis (e.g. gender differ-
ences), for moderator analysis (e.g. the influence of pa-
tient distress), and to account for confounding variables
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(e.g. baseline differences, sex, age). Qualitative data from
session S3 will be recorded, transcribed, coded, and
analyzed in accordance with Mayring’s approach to
qualitative content analysis [84].
Sample size
Sample size calculations for this study are adjusted for
intervention effects on psychological quality of life (i.e.
the primary outcome). A systematic review [85] suggests
that medium-sized effects are most likely to be expected
for the impact of music therapy on psychosocial out-
comes in palliative care. Our own studies support this
assumption finding effect sizes varying between d = 0.35
and d = 0.80 for generic quality-of-life measures [40].
Recent articles [82, 86] on sample size calculations
emphasize the superiority of ANCOVA models for ana-
lyzing the results of RCTs over the repeated-measures
ANOVA approach, as the inclusion of pretest values as a
covariate increases statistical power. Assuming statistical
power of (1- α) = 0.8, type-I error probability of α = 0.05,
and a correlation between covariate and outcome of
ρ = 0.6, a total sample size of N = 84 is required to
detect medium sized effects of d = .50 between
groups [86]. With an expected dropout rate of ap-
proximately 25%, N = 104 participants need to be
recruited for this study.
Discussion
We present the protocol of a randomized controlled trial
on the emotional, spiritual, and biological effects of the
“Song of Life” intervention for patients receiving pallia-
tive care. Our decisions for the chosen research methods
are the result of intensive, critical and interdisciplinary
discourse between researchers and clinicians from
psychology, medicine, and music therapy. Although we
are confident to have designed a robust and sound
approach to study the effects of the SOL intervention,
we would like to discuss some potential methodological
pitfalls.
First, the design of an appropriate control intervention
is crucial for the interpretation of effects. Most studies
on psychosocial interventions in palliative care compare
the actual treatment to a “standard care” or “treatment
as usual” group. While it is more likely to identify sig-
nificant effects in comparison to a group that does not
receive any additional treatment, these effects cannot be
causally attributed to the intervention, as attentional,
expectancy and other biases can play a role. Moreover, it
can be argued that it is unethical to include terminally ill
patients in a study and then withhold a potentially
effective treatment. In a previous trial, we therefore
compared a music therapy relaxation exercise to a prere-
corded verbal relaxation exercise [87]. While this was a
methodological improvement over many studies in the
field, we still could not rule out the possibility that the
personal attendance to the patient in the experimental
group contributed to the observed effects. Hence, we de-
cided to use an active and effective control intervention
carried out by trained therapists in the present study.
We did not include a third “standard care” arm as this
could raise ethical concerns and would have further
increased the required number of participants.
We are aware that direct comparison to an active con-
trol treatment will diminish the magnitude of observed
effects because we expect the relaxation exercises to lead
to substantial improvements as well. This could become
particularly challenging, as our pilot study showed only
medium-sized effects from pre to post for the unmodi-
fied version of the SOL [50]. However, our response was
not to dilute the study design, but to put effort in
optimizing the treatment and selecting appropriate
outcomes. We would like to encourage all readers to
interpret the upcoming results of the study accordingly:
Non-significant findings would not mean “not effective”
but rather “not more effective than relaxation exercises”,
while significant findings in the expected direction
would mean “even more effective than relaxation
exercises”.
We believe the major strengths of this study to be the
innovative intervention that was specifically designed to
address the needs of patients nearing the end of life and
the comprehensive assessment plan including emotional,
spiritual, and biological outcomes. Moreover, the com-
parison to an active control treatment is unique in the
study of music therapy in palliative care and will signifi-
cantly reduce the likelihood of attention and expectation
bias [88]. Finally, we would like to emphasize that the
present paper is an a priori study protocol, which means
that the primary and secondary outcomes were regis-
tered and made public before the first patient was
randomized which will diminish the risk of “p-hacking”
and reporting bias.
The present study will help to understand the poten-
tial of psychosocial interventions for terminally ill
patients and will particularly contribute to the evidence
base of creative-arts based therapies in palliative care.
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